THERAPEUTICSMD INC (TXMD) Stock News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Mentions: TNXP HCTI INTS HSDT ...

12 Health Care Stocks Moving In Monday's Intraday Session

Mentions: BLRX VSTM VERA PCSA ...

TherapeuticsMD Announces First Quarter 2025 Financial Results

TherapeuticsMD Announces Full Year 2024 Financial Results

TXMD Stock Earnings: TherapeuticsMD Reported Results for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips TherapeuticsMD (NASDAQ:TXMD) just reported results for the second quarter of 20...

TXMD Stock Earnings: TherapeuticsMD Reported Results for Q2 2024

TherapeuticsMD just reported results for the second quarter of 2024.

TherapeuticsMD Announces Third Quarter 2024 Financial Results

TherapeuticsMD Announces Second Quarter 2024 Financial Results

TXMD Stock Earnings: TherapeuticsMD Reported Results for Q4 2023

TherapeuticsMD just reported results for the fourth quarter of 2023.

TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips TherapeuticsMD (NASDAQ:TXMD) just reported results for the first quarter of 202...

TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024

TherapeuticsMD just reported results for the first quarter of 2024.

TherapeuticsMD Announces First Quarter 2024 Financial Results

TherapeuticsMD Announces Full Year 2023 Financial Results

TherapeuticsMD exploring strategic alternatives for company (NASDAQ:TXMD)

TherapeuticsMD (TXMD) said it is exploring strategic alternatives for the company, including a possible business combination or asset sale. Read more here.

TherapeuticsMD Announces Third Quarter 2023 Financial Results

TherapeuticsMD Announces Second Quarter 2023 Financial Results

TherapeuticsMD Announces First Quarter 2023 Financial Results

TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting off the week with a breakdown of the biggest pre-market stock movers traders will want to watch for Monday!

Mentions: ALLR PLRX VERB HLBZ ...

TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

TherapeuticsMD Announces Third Quarter 2022 Financial Results

TherapeuticsMD Announces Additional $7 Million Private Placement

TherapeuticsMD Announces $7 Million Private Placement

TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers